Personalised therapy in follicular lymphoma – is the dial turning? by Linton, Kim M., Specht, Lena, Pavlovsky, Astrid, Thompson, Carrie A., Kimby, Eva, Jong, Daphne, Nastoupil, Loretta J., Cottereau, Anne‐Ségolène, Casulo, Carla, Sarkozy, Clémentine, Okosun, Jessica

Get full text

FLIPI24: An Improved International Prognostic Model Developed on Early Events in Follicular Lymphoma by Maurer, Matthew J., Prochazka, Vit K, Flowers, Christopher R., Jakobsen, Lasse Hjort, Villa, Diego, Weibull, Caroline E., Cahn, Elliot J., Smith, Alexandra, Ghesquieres, Herve, Kridel, Robert, Gandhi, Maher, Cheah, Chan Y., Hawkes, Eliza, Seymour, John F., Freeman, Ciara L., Clausen, Michael Roost, Wahlin, Björn E, Friedberg, Jonathan W., Casulo, Carla, Habermann, Thomas M., Wang, Yucai, Nastoupil, Loretta J., Brown, Peter De Nully, Belada, David, Janíková, Andrea, Mocikova, Heidi, Fürst, Tomáš, Burack, Richard, Martin, Peter, Cohen, Jonathon B., Lossos, Izidore S., Kahl, Brad S., Link, Brian K., Smedby, Karin E., Sehn, Laurie H., Trneny, Marek, El-Galaly, Tarec Christoffer Christoffer, Cerhan, James R.

Get full text

TRANSCEND FL: Phase II Study Results of Lisocabtagene Maraleucel (Liso-Cel) in Patients With R/R Follicular Lymphoma (FL) by Nastoupil, LJ, Dahiya, S, Palomba, ML, Garcia-Sancho, AM, Ortega, JLR, Kuruvilla, J, Jager, U, Cartron, G, Izutsu, KI, Dreyling, M, Kahl, B, Ghesquieres, H, Ardeshna, K, Goto, H, Barbui, AM, Abramson, JS, Borchmann, P, Fleury, I, Mielke, S, Farazi, T, Fasan, O, Lymp, J, Vedal, M, Nishii, R, Avilion, A, Papuga, J, Morschhauser, F

Get full text

Harnessing the immune system through programmed death-1 blockade in the management of Hodgkin lymphoma by Oncale, Melody B, Maymani, Hossein, Nastoupil, Loretta J

Get full text

TRANSCEND FL: Phase 2 Study Primary Analysis of Lisocabtagene Maraleucel as SecondLine Therapy in Patients with High-Risk Relapsed or Refractory Follicular Lymphoma by Morschhauser, F, Dahiya, S, Palomba, ML, Garcia-Sancho, AM, Reguera, JL, Kuruvilla, J, Jaeger, U, Cartron, G, Izutsu, K, Dreyling, M, Kahl, BS, Ghesquieres, H, Ardeshna, K, Goto, H, Barbui, AM, Abramson, JS, Borchmann, P, Fleury, I, Mielke, S, Skarbnik, A, de Vos, S, Kamdar, M, Karmali, R, Viardot, A, Farazi, T, Fasan, O, Lymp, J, Vedal, M, Nishii, R, Avilion, A, Papuga, J, Nastoupil, LJ

Get full text

HIGH RESPONSE RATES WITH PEMBROLIZUMAB IN COMBINATION WITH RITUXIMAB IN PATIENTS WITH RELAPSED FOLLICULAR LYMPHOMA: INTERIM RESULTS OF AN ON OPEN‐LABEL, PHASE II STUDY by Nastoupil, L.J., Westin, J., Fowler, N., Fanale, M., Samaniego, F., Oki, Y., Obi, C., Cao, J., Cheng, X., Ma, M., Wang, Z., Chu, F., Feng, L., Zhou, S., Davis, R.E., Neelapu, S.S.

Get full text

Treatment Strategies for Patients with Diffuse Large B-Cell Lymphoma: Past, Present, and Future by Sinha, Rajni, Nastoupil, Loretta, Flowers, Christopher R

Get full text

VENETOCLAX (VEN), BENDAMUSTINE (B) AND RITUXIMAB (R) IN PATIENTS (PTS) WITH RELAPSED OR REFRACTORY (R/R) NON‐HODGKIN LYMPHOMA (NHL): FINAL RESULTS OF a PHASE I STUDY by Swinnen, L.J., Flowers, C.R., Wang, D., Reid, E., Fowler, N., Cordero, J., Dunbar, M., Enschede, S., Nolan, C., Petrich, A.M., Ross, J., Salem, A.H., Verdugo, M., Wong, S., Zhou, L., Kozloff, M., Nastoupil, L., Vos, S.

Get full text